News

Pfizer, the partner of Antares, has achieved development milestone related to its undisclosed consumer healthcare product. In December 2011 Antares licensed one of its drug delivery technologies to

Under the cooperative research and development agreement (CRADA), the company will test the efficacy of the wound gel containing antimicrobial peptide KSL-W and DispersinB antibiofilm enzyme in killing

Hirak Basu, Colby’s chief scientific officer and George Wilding, SAB Co-Chairman, in collaboration with University of Wisconsin-Madison’s researchers showed hydrogen peroxide production from enzymatic oxidation of spermine and

As part of the grant, AvidBiotics will receive $600,000 funds spreading over two years. AvidBiotics chief executive officer David Martin said Clostridium difficile has become the most frequent

Catalent Modified Release Technologies president Ian Muir said Catalent is pleased to have partnered with VIVUS to develop Qsymia and look forward to a long and successful relationship.

ANMAT has previously approved the sale of Naturaferon in Argentina to treat recurring external condylomata acuminata (genital warts). The company has filed the new NDA with ANMAT keeping

Dynaflex director Gaurav Vora was quoted by Business Standard as saying that the company sees potential in the pharma industry with drug makers looking to offer products in

As a part of the agreement, Ablynx will be responsible for the discovery of Nanobody candidates while Merck will be responsible for the research, development, manufacturing and commercialisation

Mydicar, intended to restore levels of SERCA2a, a regulator of calcium cycling in the heart and cardiac contractility, is delivered directly to the heart in a single dose